SI0874855T1 - Production of a salt of clavulanic acid - Google Patents

Production of a salt of clavulanic acid

Info

Publication number
SI0874855T1
SI0874855T1 SI9630672T SI9630672T SI0874855T1 SI 0874855 T1 SI0874855 T1 SI 0874855T1 SI 9630672 T SI9630672 T SI 9630672T SI 9630672 T SI9630672 T SI 9630672T SI 0874855 T1 SI0874855 T1 SI 0874855T1
Authority
SI
Slovenia
Prior art keywords
clavulanic acid
pct
butanol
production
salt
Prior art date
Application number
SI9630672T
Other languages
English (en)
Slovenian (sl)
Inventor
Helmut Wagner
Original Assignee
Biochemie Gesellschaft M.B.H.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gesellschaft M.B.H. filed Critical Biochemie Gesellschaft M.B.H.
Publication of SI0874855T1 publication Critical patent/SI0874855T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D503/02—Preparation
    • C07D503/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D503/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
SI9630672T 1995-11-15 1996-11-14 Production of a salt of clavulanic acid SI0874855T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0186795A AT403375B (de) 1995-11-15 1995-11-15 Verfahren zur fällung von alkalisalzen der clavulansäure
EP96939048A EP0874855B1 (en) 1995-11-15 1996-11-14 Production of a salt of clavulanic acid
PCT/EP1996/005015 WO1997018216A1 (en) 1995-11-15 1996-11-14 Production of a salt of clavulanic acid

Publications (1)

Publication Number Publication Date
SI0874855T1 true SI0874855T1 (en) 2004-06-30

Family

ID=3522721

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9630672T SI0874855T1 (en) 1995-11-15 1996-11-14 Production of a salt of clavulanic acid

Country Status (24)

Country Link
US (1) US6133441A (cs)
EP (1) EP0874855B1 (cs)
JP (1) JP4319252B2 (cs)
KR (1) KR100537732B1 (cs)
CN (1) CN1090636C (cs)
AT (2) AT403375B (cs)
AU (1) AU714017B2 (cs)
BR (1) BR9611572A (cs)
CA (1) CA2237763C (cs)
CZ (1) CZ296567B6 (cs)
DE (1) DE69631608T2 (cs)
ES (1) ES2216073T3 (cs)
HU (1) HUP9903478A3 (cs)
IL (1) IL124353A (cs)
MX (1) MX9803887A (cs)
NO (1) NO982107L (cs)
NZ (1) NZ322485A (cs)
PL (1) PL188634B1 (cs)
RU (1) RU2179171C2 (cs)
SI (1) SI0874855T1 (cs)
SK (1) SK285138B6 (cs)
TR (1) TR199800860T2 (cs)
TW (1) TW427991B (cs)
WO (1) WO1997018216A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
CA2424462C (en) * 2000-10-20 2010-03-30 Biochemie Gesellschaft M.B.H. Clavulanic acid pharmaceutical compositions
CA2935651A1 (en) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Broad spectrum beta-lactamase inhibitors
WO2010118361A1 (en) * 2009-04-09 2010-10-14 Sopharmia, Inc. Beta lactamase inhibitors
WO2014165126A2 (en) 2013-03-12 2014-10-09 Sopharmia, Inc. Derivatized 3-styryl-cephalosporins
CN109535184B (zh) * 2017-09-21 2020-11-20 联邦制药(内蒙古)有限公司 一种克拉维酸叔辛胺制备克拉维酸钾的方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) * 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
US4144242A (en) * 1975-02-07 1979-03-13 Glaxo Laboratories Limited Process for the purification of clavulanic acid
GB2003863B (en) * 1977-09-01 1982-03-31 Beecham Group Ltd Chemical process
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
AU600655B2 (en) * 1984-10-27 1990-08-23 Beecham Group Plc Preparation of clavulanic acid and its salts and esters
GB8618888D0 (en) * 1986-08-01 1986-09-10 Davy Mckee Ltd Process
US5679789A (en) * 1987-01-29 1997-10-21 Beecham Group, P.L.C. Pharmaceutical compositions comprising potassium clavulanate and methods of using them
IT1227072B (it) * 1987-01-29 1991-03-14 Beecham Group Plc Clavulanato di potassio, procedimento per la sua produzione e composizione farmaceutica
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
US5210296A (en) * 1990-11-19 1993-05-11 E. I. Du Pont De Nemours And Company Recovery of lactate esters and lactic acid from fermentation broth
AT400033B (de) * 1992-03-10 1995-09-25 Biochemie Gmbh Neues verfahren zur isolierung und reinigung von clavulansäure und zur herstellung von pharmakologisch verträglichen salzen derselben
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9200139A (en) * 1992-07-08 1994-03-31 Lek Tovarna Farmacevtskih New inclusion complex of clavulanic acid with hydrophylyc and hydropholyc beta-cyclodextrin derivates for production of them
KR100200239B1 (ko) * 1992-10-21 1999-06-15 김충환 클라불란산 칼륨염의 제조방법
GB9401969D0 (en) * 1994-02-02 1994-03-30 Smithkline Beecham Plc Process
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB2298201B (en) * 1995-02-25 1997-05-28 Spurcourt Ltd Clavulanic acid salts
DE69618045D1 (de) * 1995-02-25 2002-01-31 Spurcourt Ltd Clavulansäure Salz
SI9500074A (en) * 1995-03-10 1996-10-31 Lek Tovarna Farmacevtskih Process for preparation of alkani salts of clavulanic acid.
SI9500134B (sl) * 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
KR100200242B1 (ko) * 1995-05-16 1999-06-15 김충환 클라불란산염의 제조 방법
GB9515809D0 (en) * 1995-08-02 1995-10-04 Smithkline Beecham Plc Process
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
ZA975198B (en) * 1996-06-13 1997-12-15 Smithkline Beecham Corp Improved process for preparing potassium clavulanate.
CN1238776A (zh) * 1996-11-11 1999-12-15 吉斯特-布罗卡迪斯有限公司 制备棒酸盐和酯的方法

Also Published As

Publication number Publication date
SK64098A3 (en) 1998-10-07
ATE259817T1 (de) 2004-03-15
BR9611572A (pt) 1999-03-30
NO982107D0 (no) 1998-05-08
KR100537732B1 (ko) 2006-04-14
JP2000500149A (ja) 2000-01-11
US6133441A (en) 2000-10-17
CA2237763C (en) 2008-05-06
EP0874855B1 (en) 2004-02-18
PL326696A1 (en) 1998-10-26
RU2179171C2 (ru) 2002-02-10
MX9803887A (es) 1998-09-30
HK1016971A1 (en) 1999-11-12
AT403375B (de) 1998-01-26
CZ149198A3 (cs) 1998-08-12
ES2216073T3 (es) 2004-10-16
CA2237763A1 (en) 1997-05-22
PL188634B1 (pl) 2005-03-31
CN1204337A (zh) 1999-01-06
IL124353A (en) 2005-06-19
ATA186795A (de) 1997-06-15
KR19990067480A (ko) 1999-08-25
EP0874855A1 (en) 1998-11-04
JP4319252B2 (ja) 2009-08-26
DE69631608D1 (de) 2004-03-25
SK285138B6 (sk) 2006-07-07
HUP9903478A3 (en) 2000-05-29
AU714017B2 (en) 1999-12-16
HUP9903478A2 (hu) 2000-03-28
TR199800860T2 (xx) 2000-07-21
NZ322485A (en) 2000-01-28
WO1997018216A1 (en) 1997-05-22
NO982107L (no) 1998-05-08
IL124353A0 (en) 1998-12-06
DE69631608T2 (de) 2004-12-23
TW427991B (en) 2001-04-01
CN1090636C (zh) 2002-09-11
AU7625096A (en) 1997-06-05
CZ296567B6 (cs) 2006-04-12

Similar Documents

Publication Publication Date Title
AU697015B2 (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
DK0889875T3 (da) Cycloproylalkansyrederivater
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
DE69332259D1 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
AU2135695A (en) Pyrimidine or triazine carboxylic acid derivatives to be used as medicaments
IL124353A (en) Production of a potassium salt of clavulanic acid
TW252979B (cs)
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
ES8502119A1 (es) Un procedimiento para la produccion de derivados del acido penicilanico
DK0871632T3 (da) Produktion af et krystallinsk salt af amoxycillin
DK0725785T3 (da) Fremgangsmåde til fremstilling af rufloxacin af deraf
ATE80629T1 (de) Beta-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln.
AU7351787A (en) 2,2,6,6-diethylene-3-oxo-17-alpha-pregn-4-en-21,17- carbolactones
MX9701220A (es) Antagonistas de endotelina.